Guidelines for the clinical evaluation of antineoplastic drugs.
Series: HHS publication -- no. (FDA) 81-3112
Publisher: U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration
Place of publication: Rockville, MD